Researchers are exploring the use of bacteria, including common food-borne bacteria, as a potential approach to treating colorectal cancer. This method, referred to as microbial cell therapy or "bugs as drugs," involves using microbes to deliver cytotoxins or other therapeutic agents to target cancer cells. The concept of using microbes as therapeutics is being studied for its implications on various aspects of health, including cancer treatment and gut health.